BioElectronics Corporation

BioElectronics Corporation is a Maryland-based medical device manufacturer specializing in non-invasive electroceutical devices for drug-free pain relief. The company develops and markets pulsed shortwave therapy (PSWT) devices, including ActiPatch® and RecoveryRx®, designed for musculoskeletal and soft-tissue pain management, as well as phantom and residual limb pain. Products are indicated for treatment of general musculoskeletal pain and are marketed through distribution partnerships including KT Health, Scott Specialties (OTC channel), and Medi-Launch (prescription medical market). The company has earned CE Mark certification for European and international distribution (33+ countries) and has filed FDA 510(k) applications for expanded market clearance. Clinical data demonstrates comparative efficacy to prescription-strength NSAIDs. Distribution agreements are active in Spain (PRIM Group) and Mexico (Cofepris clearance via Novro Med S.A. de C.V.). The company is publicly traded on OTC markets (ticker: BIEL) and has demonstrated significant year-over-year revenue growth. Manufacturing and sales focus on both professional healthcare settings and over-the-counter consumer markets.